M. Guidotti

Progress in the development of oxytocin antagonists for use in preterm labor.

B. E. Evans, M. Bock, D. Reiss, 1995, Advances in experimental medicine and biology.

Cloning and expression of the rhesus monkey oxytocin receptor.

M. Jacobson, D. Pettibone, C. Salvatore, 1998, Journal of receptor and signal transduction research.

L‐368,899, a potent orally active oxytocin antagonist for potential use in preterm labor

B. E. Evans, M. Kaufman, D. Veber, 1993 .

Nonpeptide oxytocin antagonists: analogs of L-371,257 with improved potency.

B. E. Evans, M A Jacobson, M. Bock, 1999, Bioorganic & medicinal chemistry letters.

1-(1-[4-[(N-acetyl-4-piperidinyl)oxy]-2-methoxybenzoyl]piperidin-4- yl)-4H-3,1-benzoxazin-2(1H)-one (L-371,257): a new, orally bioavailable, non-peptide oxytocin antagonist.

D. Veber, R. Freidinger, D. Reiss, 1995, Journal of medicinal chemistry.

Development of orally active oxytocin antagonists: studies on 1-(1-[4-[1-(2-methyl-1-oxidopyridin-3-ylmethyl)piperidin-4-yloxy]-2- methoxybenzoyl]piperidin-4-yl)-1,4-dihydrobenz[d][1,3]oxazin-2-one (L-372,662) and related pyridines.

S Vickers, R. Freidinger, D. Reiss, 1998, Journal of medicinal chemistry.